|
1
|
Wittekindt C, Wagner S, Mayer CS and
Klußmann JP: Basics of tumor development and importance of human
papilloma virus (HPV) for head and neck cancer.
Laryngorhinootologie. 91(Suppl 1): S1–S26. 2012.(In German).
PubMed/NCBI
|
|
2
|
Landis SH, Murray T, Bolden S and Wingo
PA: Cancer statistics, 1999. CA Cancer J Clin. 49:8–31. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hall SF, Groome PA, Irish J and O'Sullivan
B: The natural history of patients with squamous cell carcinoma of
the hypopharynx. Laryngoscope. 118:1362–1371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu S, Gu JC, Liang J, Yu T and Dong XH:
Expression and clincal significance of Survivin and PTEN in
hypopharyngeal squamous cell carcinoma. Guangdong Yi Xue.
33:1958–1960. 2012.(In Chinese).
|
|
5
|
Lang S, Wollenberg B, Dellian M, et al:
Clinical and epidemiological data of patients with malignomas of
the head and neck. Laryngorhinootologie. 81:499–508. 2002.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boyle P and Ferlay J: Cancer incidence and
mortality in Europe, 2004. Ann Oncol. 16:481–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rose BS, Jeong JH, Nath SK, Lu SM and Mell
LK: Population-based study of competing mortality in head and neck
cancer. J Clin Oncol. 29:3503–3509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takes RP, Strojan P, Silver CE, Bradley
PJ, Haigentz M Jr, Wolf GT, Shaha AR, Hartl DM, Olofsson J,
Langendijk JA, et al: International Head and Neck Scientific Group:
Current trends in initial hypopharyngeal cancer: The declining use
of open surgery. Head Neck. 34:270–281. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Srinivas PR, Kramer BS and Srivastava S:
Trends in biomarker research for cancer detection. Lancet Oncol.
2:698–704. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
González-Mariscal L, Betanzos A, Nava P
and Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol.
81:1–44. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gumbiner BM: Cell adhesion: The molecular
basis of tissue Architecture and morphogenesis. Cell. 84:345–357.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heiskala M, Peterson PA and Yang Y: The
roles of claudin superfamily proteins in paracellular transport.
Traffic. 2:93–98. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harhaj NS and Antonetti DA: Regulation of
tight junctions and loss of barrier function in pathophysiology.
Int J Biochem Cell Biol. 36:1206–1237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishida M, Kushima R and Okabe H: Claudin
expression in rectal well-differentiated endocrine neoplasms
(carcinoid tumors). Oncol Rep. 21:113–117. 2009.PubMed/NCBI
|
|
16
|
Fritzsche FR, Oelrich B, Johannsen M,
Kristiansen I, Moch H, Jung K and Kristiansen G: Claudin-1 protein
expression is a prognostic marker of patient survival in renal cell
carcinomas. Clin Cancer Res. 14:7035–7042. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Soini Y and Talvensaari-Mattila A:
Expression of claudins 1, 4, 5, and 7 in ovarian tumors of diverse
types. Int J Gynecol Pathol. 25:330–335. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Resnick MB, Gavilanez M, Newton E, Konkin
T, Bhattacharya B, Britt DE, Sabo E and Moss SF: Claudin expression
in gastric adenocarcinomas: A tissue microarray study with
prognostic correlation. Hum Pathol. 36:886–892. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huo Q, Kinugasa T, Wang L, Huang J, Zhao
J, Shibaguchi H, Kuroki M, Tanaka T, Yamashita Y, Nabeshima K, et
al: Claudin-1 protein is a major factor involved in the
tumorigenesis of colorectal cancer. Anticancer Res. 29:851–857.
2009.PubMed/NCBI
|
|
20
|
de Oliveira SS, de Oliveira IM, De Souza W
and Morgado-Díaz JA: Claudins upregulation in human colorectal
cancer. FEBS Lett. 579:6179–6185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krämer F, White K, Kubbies M, Swisshelm K
and Weber BH: Genomic organization of claudin-1 and its assessment
in hereditary and sporadic breast cancer. Hum Genet. 107:249–256.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tokés AM, Kulka J, Paku S, Szik A, Páska
C, Novák PK, Szilák L, Kiss A, Bögi K and Schaff Z: Claudin-1, −3
and −4 proteins and mRNA expression in benign and malignant breast
lesions: A research study. Breast Cancer Res. 7:R296–R305. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chao YC, Pan SH, Yang SC, Yu SL, Che TF,
Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, et al: Claudin-1 is a
metastasis suppressor and correlates with clinical outcome in lung
adenocarcinoma. Am J Respir Crit Care Med. 179:123–133. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Swisshehn K, Macek R and Kubbies M: Role
of claudins in tumorigenesis. Adv Drug Deliv Rev. 57:919–928. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsueh C, Chang YS, Tseng NM, Liao CT,
Hsueh S, Chang JH, Wu IC and Chang KP: Expression pattern and
prognostic significance of claudins 1, 4, and 7 in nasopharyngeal
carcinoma. Hum Pathol. 41:944–950. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Elledge SJ: Cell cycle checkpoints:
Preventing an identity crisis. Science. 274:1664–1672. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Karagoz ID, Ozaslan M, Cengiz B, Kalender
ME, Kilic IH, Oztuzcu S, Gogebakan B and Demiryurek AT: CDC 25A
gene 263C/T, −350C/T and −51C/G polymorphisms in breast carcinoma.
Tumour Bio1. 31:597–604. 2010. View Article : Google Scholar
|
|
29
|
Brandeis M, Rosewell I, Carrington M,
Crompton T, Jacobs MA, Kirk J, Gannon J and Hunt T: Cyclin B2-null
mice develop normally and are fertile whereas cyclin B1-null mice
die in utero. Proc Natl Acad Sci USA. 95:4344–4349. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barrett KL, Demiranda D and Katula KS:
Cyclin b1 promoter activity and functional cdk1 complex formation
in G1 phase of human breast cancer cells. Cell Biol Int. 26:19–28.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yasuda M, Takesue F, Inutsuka S, Honda M,
Nozoe T and Korenaga D: Overexpression of cyclin B1 in gastric
cancer and its clinicopathological significance: An
immunohistological study. J Cancer Res Clin Oncol. 28:412–416.
2002. View Article : Google Scholar
|
|
32
|
Soria JC, Jang SJ, Khuri FR, Hassan K, Liu
D, Hong WK and Mao L: Overexpression of cyclin B1 in early-stage
non-small cell lung cancer and its clinical implication. Cancer
Res. 60:4000–4004. 2000.PubMed/NCBI
|
|
33
|
Grabsch H, Lickvers K, Hansen O, Takeno S,
Willers R, Stock W, Gabbert HE and Mueller W: Prognostic value of
cyclin B1 protein expression in colorectal cancer. Am J Clin
Pathol. 122:511–516. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mashal RD, Lester S, Corless C, Richie JP,
Chandra R, Propert KJ and Dutta A: Expression of cell
cycle-regulated proteins in prostate cancer. Cancer Res.
56:4159–4163. 1996.PubMed/NCBI
|
|
35
|
Song Y, Zhao C, Dong L, Fu M, Xue L, Huang
Z, Tong T, Zhou Z, Chen A, Yang Z, et al: Overexpression of cyclin
B1 in human esophageal squamous cell carcinoma cells induces tumor
cell invasive growth and metastasis. Carcinogenesis. 29:307–315.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao M, Kim YT, Yoon BS, Kim SW, Kang MH,
Kim SH, Kim JH, Kim JW and Park YW: Expression profiling of cyclin
B1 and D1 in cervical carcinoma. Exp Oncol. 28:44–48.
2006.PubMed/NCBI
|
|
37
|
Murakami H, Furihata M, Ohtsuki Y and
Ogoshi S: Determination of the prognostic significance of cyclin B1
overexpression in patients with esophageal squamous cell carcinoma.
Virchows Arch. 434:153–158. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takeno S, Noguchi T, Kikuchi R, Uchida Y,
Yokoyama S and Müller W: Prognostic value of cyclin B1 in patients
with esophageal squamous cell carcinoma. Cancer. 94:2874–2881.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hassan KA, El-Naggar AK, Soria JC, Liu D,
Hong WK and Mao L: Clinical significance of cyclin B1 protein
expression in squamous cell carcinoma of the tongue. Clin Cancer
Res. 7:2458–2462. 2001.PubMed/NCBI
|
|
40
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumors (7th). Wiley-Blackwell.
Hoboken, NJ: 2009.
|
|
41
|
Yuan J, Krämer A, Matthess Y, Yan R,
Spänkuch B, Gätje R, Knecht R, Kaufmann M and Strebhardt K: Stable
gene silencing of cyclin B1 in tumor cells increases susceptibility
to taxol and leads to growth arrest in vivo. Oncogene.
25:1753–1762. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Stark GR and Taylor WR: Control of the
G2/M transition. Mol Biotechnol. 32:227–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nurse P: Ordering S phase and M phase in
the cell cycle. Cell. 79:547–550. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nigg EA: The substrates of the cdc2
kinase. Semin Cell Biol. 2:261–270. 1991.PubMed/NCBI
|
|
45
|
Farhana L, Dawson M, Rishi AK, Zhang Y,
Van Buren E, Trivedi C, Reichert U, Fang G, Kirschner MW and
Fontana JA: Cyclin B and E2F-1 expression in prostate carcinoma
cells treated with the novel retinoid CD437 are regulated by the
ubiquitin-mediated pathway. Cancer Res. 62:3842–3849.
2002.PubMed/NCBI
|
|
46
|
Cukier IH, Li Y and Lee JM: Cyclin B1/Cdkl
binds and phosphorylates filamin A and regulates its ability to
cross-link actin. FEBS Lett. 581:1661–1672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hoffmann TK, Trellakis S, Olulicz K,
Schuler P, Greve J, Arnolds J, Bergmann C, Bas M, Lang S, Lehnerdt
G, et al: Cyclin B1 Expression and p53 Status in Squamous Cell
Carcinomas of the Head and Neck. A NTICANCER R ESEARCH.
31:3151–3158. 2011.
|
|
48
|
Barascu A, Besson P, Le Floch O, Bougnoux
P and Jourdan ML: CDK1-cyclin B1 mediates the inhibition of
proliferation induced by omega-3 fatty acids in MDA-MB-231 breast
cancer cells. Int J Biochem Cell Biol. 38:196–208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Krause G, Winkler L, Mueller SL, Haseloff
RF, Piontek J and Blasig IE: Structure and function of claudins.
Biochim Biophys Acta. 1778:631–645. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dhawan P, Singh AB, Deane NG, No Y, Shiou
SR, Schmidt C, Neff J, Washington MK and Beauchamp RD: Claudin-1
regulates cellular transformation and metastatic behavior in colon
cancer. J Clin Invest. 115:1765–1776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dos Reis PP, Bharadwaj RR, Machado J,
Macmillan C, Pintilie M, Sukhai MA, Perez-Ordonez B, Gullane P,
Irish J and Kamel-Reid S: Claudin 1 overexpression increases
invasion and is associated with aggressive histological features in
oral squamous cell carcinoma. Cancer. 113:3169–3180. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Oku N, Sasabe E, Ueta E, Yamamoto T and
Osaki T: Tight junction protein claudin-1 enhances the invasive
activity of oral squamous cell carcinoma cells by promoting
cleavage of laminin-5 gamma2 chain via matrix metalloproteinase
(MMP)-2 and membrane-type MMP-1. Cancer Res. 66:5251–5257. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
de la Peña S, Sampieri CL and León-Córdoba
K: Matrix metalloproteases as molecular markers in gastric cancer.
Med Clin (Barc). 134:123–126. 2010.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yoon CH, Kim MJ, Park MJ, Park IC, Hwang
SG, An S, Choi YH, Yoon G and Lee SJ: Claudin-1 acts through
c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal
role in the acquisition of invasive capacity in human liver cells.
J Biol Chem. 285:226–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kawamoto H, Uozumi T, Kawamoto K, Arita K,
Yano T and Hirohata T: Type IV collagenase activity and cavernous
sinus invasion in human pituitary adenomas. Acta Neurochir (Wien).
138:390–395. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Arabzadeh A, Troy TC and Turksen K: Role
of the Cldn6 cytoplasmic tail domain in membrane targeting and
epidermal differentiation in vivo. Mol Cell Biol. 26:5876–5887.
2006. View Article : Google Scholar : PubMed/NCBI
|
